Amgen, Inc. (NASDAQ:AMGN)

biotech word cloud

Short Sellers Grow More Aggressive on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
upside

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

If any sector has had a tough go of it the past year, it has been health care, and especially biotechnology. Continued harsh rhetoric from politicians, especially the Democrats, over ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
hammered

6 Companies That Destroyed Shareholders Last Week

The broad markets are holding steady near their double bottom set this summer. However, over the course of the past week this has been tested. Quite a few companies were ...
Read Full Story »
coins

Amgen Sinks Despite Beating Street Estimates

When Amgen Inc. (NASDAQ: AMGN) reported its third-quarter financial results after the markets closed on Thursday, the company said that it had $3.02 in earnings per share (EPS) and $5.81 ...
Read Full Story »
Female patient on gurney

What to Watch When Amgen Reports Earnings

Amgen Inc. (NASDAQ: AMGN) is scheduled to release its third-quarter financial results after the markets close on Thursday. Consensus estimates from Thomson Reuters call for $2.79 in earnings per share ...
Read Full Story »
biotech word cloud

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, October 14. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest players in the health care sector. This current quarter ahead ...
Read Full Story »
Pills and tablets

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

It is no secret that the health care system in America needs help. Treatment costs have gone through the roof over the past two decades, and there is an ongoing ...
Read Full Story »
graph

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

It’s a tired refrain, as we have written about it for over a year, but the beating that the health care sector has taken, especially the biotechs, may be providing ...
Read Full Story »
biotech word cloud

Short Sellers Have Mixed Views on Major Biotechs

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
money

How Much Will Consumers Save on New Humira Biosimilar?

Some interesting news that hit late last week may have been much larger news had not been going into the weekend. In a time when government wrangling about drug prices ...
Read Full Story »
Test tubes

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

We have talked in detail about how the political rhetoric has weighed upon the biotech industry. Toss in some scrutiny of pricing over a widely used product, and you have ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside. In fact, a cure or incredible new breakthrough in cancer ...
Read Full Story »